China Traditional Chinese Medicine Holdings Co. Limited announced the retirement of its auditor, Ernst & Young (E&Y), due to regulatory requirements limiting the duration an accounting firm can provide auditing services to central state-owned enterprises and their subsidiaries. As a subsidiary of China National Pharmaceutical Group Co., Ltd., the company is subject to these regulations. E&Y had not yet commenced audit work for the financial year ending December 31, 2025, and the Board confirmed that this change would not significantly impact the annual audit and results release. The company is actively seeking a suitable replacement and will announce the new auditor when appointed.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。